SSIC RSI Chart
Last 7 days
6.5%
Last 30 days
13.1%
Last 90 days
44.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 3.6M | 5.2M | 6.3M | 6.6M |
2022 | 10.1K | 899.5K | 1.8M | 2.7M |
2021 | 0 | 0 | 0 | 0 |
Which funds bought or sold SSIC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Feb 14, 2024 | JACOBS ASSET MANAGEMENT, LLC | added | 21.99 | 103,060 | 1,553,560 | 1.21% |
Feb 14, 2024 | Penserra Capital Management LLC | unchanged | - | -102,000 | 699,000 | 0.01% |
Feb 13, 2024 | MORGAN STANLEY | new | - | 15.00 | 15.00 | -% |
Feb 12, 2024 | CAPSTONE INVESTMENT ADVISORS, LLC | sold off | -100 | -262,464 | - | -% |
Feb 09, 2024 | WELLS FARGO & COMPANY/MN | unchanged | - | -5,833 | 39,702 | -% |
Feb 07, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Unveiling Silver Spike Investment Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Silver Spike Investment Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 357.8B | 85.2B | 10.18 | 4.2 | ||||
MRK | 321.7B | 60.1B | 881.36 | 5.35 | ||||
PFE | 148.3B | 46.5B | -106.79 | 3.19 | ||||
AMGN | 146.3B | 28.2B | 21.78 | 5.19 | ||||
GILD | 83.6B | 27.1B | 14.75 | 3.08 | ||||
TEVA | 14.6B | 15.8B | -25.3 | 0.92 | ||||
MID-CAP | ||||||||
PRGO | 4.2B | 4.7B | -333.24 | 0.91 | ||||
ALKS | 4.1B | 1.7B | 11.58 | 2.48 | ||||
BHC | 3.1B | 8.8B | -5.28 | 0.36 | ||||
AMPH | 2.0B | 644.4M | 14.34 | 3.06 | ||||
SMALL-CAP | ||||||||
TLRY | 1.4B | 743.2M | -4.05 | 1.92 | ||||
TXMD | 22.3M | 1.3M | -2.17 | 17.09 | ||||
ACRX | 16.3M | - | -0.89 | 0.22 | ||||
AGRX | 2.7M | 19.6M | -0.19 | 0.14 | ||||
ACOR | 645.9K | 117.6M | 0 | 0.01 |
Silver Spike Investment Corp News
Income Statement (Quarterly) | ||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 7.7% | 1,741,723 | 1,616,986 | 1,899,412 | 1,370,723 | 1,425,327 | 550,415 | 221,245 | - | - |
S&GA Expenses | - | - | - | - | - | - | - | - | 34,168 | - |
Net Income | 30.0% | -1,850,234 | -2,641,361 | 1,211,404 | 2,357,080 | 1,151,979 | 559,923 | 211,737 | 85,059,639 | - |
Net Income Margin | -154.6% | -0.14 | 0.26 | 0.75 | 0.79 | 21.43 | -0.21 | -0.41 | -55.93 | - |
Free Cashflow | 749.7% | 7,138,994 | 840,198 | 351,633 | -2,581,293 | 437,400 | 437,400 | -24,147,613 | -509,110 | - |
Balance Sheet | |||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q1 |
Assets | -0.7% | 89.00 | 89.00 | 91.00 | 90.00 | 87.00 | 85.00 |
Cash Equivalents | 9.4% | 33.00 | 30.00 | 33.00 | 33.00 | 35.00 | 85.00 |
Liabilities | 69.6% | 3.00 | 2.00 | 1.00 | 1.00 | 0.00 | 0.00 |
Shareholder's Equity | -2.1% | 86.00 | 87.00 | 90.00 | 89.00 | 86.00 | 85.00 |
Retained Earnings | -80.5% | 0.00 | 2.00 | 5.00 | 4.00 | 1.00 | -0.43 |
Additional Paid-In Capital | 0.0% | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 |
Shares Outstanding | 0.0% | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Float | - | - | - | 14.00 | - | - | - |
Cashflow (Quarterly) | |||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q1 |
Cashflow From Operations | 749.7% | 7,138,994 | 840,198 | 351,633 | -2,581,293 | - | 437,400 | -24,147,613 | -509,110 | - | - |
Cashflow From Financing | -11.1% | -4,348,295 | -3,914,922 | - | - | - | - | - | 85,269,770 | - | - |
Dividend Payments | - | 4,348,295 | - | - | - | - | - | - | - | - | - |
Statements of Operations - USD ($) | 9 Months Ended | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2023 | Mar. 31, 2022 | ||||||
Non-control/non-affiliate investment income | ||||||||
Interest income | $ 3,626,792 | |||||||
Fee income | 410,000 | $ 196,251 | $ 0 | |||||
Total investment income | 4,036,792 | |||||||
EXPENSES | ||||||||
Income-based incentive fees | 0 | [1] | 1,511,253 | 0 | ||||
Management fee | 336,432 | [1] | 1,013,764 | 0 | ||||
Transaction expenses | 0 | [1] | 711,264 | 0 | ||||
Audit expense | 210,284 | [1] | 499,698 | 40,000 | ||||
Legal expenses | 484,412 | [1] | 343,824 | 34,069 | ||||
Administrator fees | 171,494 | [1] | 335,253 | 47,151 | ||||
Insurance expense | 228,288 | [1] | 269,719 | 46,488 | ||||
Director expenses | 99,845 | [1] | 200,955 | 0 | ||||
Valuation fees | 0 | [1] | 115,985 | 0 | ||||
Capital gains incentive fees | 0 | [1] | 87,583 | 0 | ||||
Other expenses | 122,070 | [1] | 85,953 | 6,808 | ||||
Professional fees | 70,264 | [1] | 70,150 | 34,920 | ||||
Custodian fees | 36,150 | [1] | 48,000 | 36,000 | ||||
Excise tax expense | 80,566 | [1] | 10,655 | 0 | ||||
Organizational expenses | 0 | [1] | 0 | 328,002 | ||||
Total expenses | 1,839,805 | [1] | 5,304,056 | 573,438 | ||||
NET INVESTMENT INCOME (LOSS) | 2,196,987 | [1] | 6,628,844 | (563,365) | ||||
NET REALIZED GAIN (LOSS) FROM INVESTMENTS | ||||||||
Net realized gain (loss) from investments | 0 | [1] | (210,767) | 0 | ||||
NET CHANGE IN UNREALIZED APPRECIATION (DEPRECIATION) FROM INVESTMENTS | ||||||||
Net change in unrealized appreciation (depreciation) from investments | (273,348) | [1] | 922,031 | 0 | ||||
Net realized and unrealized gains (losses) | (273,348) | [1] | 711,264 | 0 | ||||
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ 1,923,639 | [1] | $ 7,340,108 | $ (563,365) | ||||
NET INVESTMENT INCOME (LOSS) PER SHARE - BASIC (in dollars per share) | $ 0.35 | [1] | $ 1.07 | $ (0.64) | ||||
NET INVESTMENT INCOME (LOSS) PER SHARE - DILUTED (in dollars per share) | 0.35 | [1] | 1.07 | (0.64) | ||||
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC (in dollars per share) | 0.31 | [1] | 1.18 | (0.64) | ||||
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - DILUTED (in dollars per share) | $ 0.31 | [1] | $ 1.18 | $ (0.64) | ||||
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC (in shares) | 6,214,672 | [1],[2] | 6,214,682 | 877,409 | ||||
WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED (in shares) | 6,214,672 | [1],[2] | 6,214,682 | 877,409 | ||||
Investment, Unaffiliated Issuer [Member] | ||||||||
Non-control/non-affiliate investment income | ||||||||
Interest income | $ 3,626,792 | [1] | $ 11,736,649 | $ 10,073 | ||||
Fee income | 410,000 | [1] | 196,251 | 0 | ||||
Total investment income | 4,036,792 | [1] | 11,932,900 | 10,073 | ||||
NET REALIZED GAIN (LOSS) FROM INVESTMENTS | ||||||||
Net realized gain (loss) from investments | 0 | [1] | (210,767) | 0 | ||||
NET CHANGE IN UNREALIZED APPRECIATION (DEPRECIATION) FROM INVESTMENTS | ||||||||
Net change in unrealized appreciation (depreciation) from investments | $ (273,348) | [1] | $ 922,031 | $ 0 | ||||
|
 | Mr. Scott Gordon |
---|---|
 | Pharmaceuticals |